Skip to main content
Top
Published in: Reactions Weekly 1/2021

01-03-2021 | NSCLC | Case report

Nivolumab

Interstitial lung disease: case report

Published in: Reactions Weekly | Issue 1/2021

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Gemma A, et al. Real-World Evaluation of Factors for Interstitial Lung Disease Incidence and Radiologic Characteristics in Patients With EGFR T790M-positive NSCLC Treated With Osimertinib in Japan. Journal of Thoracic Oncology 15: 1893-1906, No. 12, Dec 2020. Available from: URL: http://doi.org/10.1016/j.jtho.2020.08.025 Gemma A, et al. Real-World Evaluation of Factors for Interstitial Lung Disease Incidence and Radiologic Characteristics in Patients With EGFR T790M-positive NSCLC Treated With Osimertinib in Japan. Journal of Thoracic Oncology 15: 1893-1906, No. 12, Dec 2020. Available from: URL: http://​doi.​org/​10.​1016/​j.​jtho.​2020.​08.​025
Metadata
Title
Nivolumab
Interstitial lung disease: case report
Publication date
01-03-2021
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-92490-2

Other articles of this Issue 1/2021

Reactions Weekly 1/2021 Go to the issue

Case report

Sodium-valproate

Case report

Multiple drugs

Case report

Regorafenib